Sri Lanka,Aug 5, 2016: In a remarkable public health achievement, Sri Lanka has been certified as malaria-free island country by World Health Organisation (WHO).
“Sri Lanka’s achievement is truly remarkable. In the mid-20th century it was among the most malaria-affected countries, but now it is malaria-free. This is testament to the courage and vision of its leaders, and signifies the great leaps that can be made when targeted action is taken.
It also demonstrates the importance of grass-roots community engagement and a whole-of-society approach when it comes to making dramatic public health gains, “WHO Regional Director, Dr Poonam Khetrapal Singh, said here.
Sri Lanka’s road to eliminating the mosquitoes was tough, and demanded well-calibrated, responsive policies. After malaria cases soared in the 1970s and 80s, the country’s anti-malaria campaign in the 1990s adjusted its strategy to intensively target the parasite in addition to targeting the mosquito. The change in strategy was unorthodox, but highly effective.
Mobile malaria clinics in high transmission areas meant that prompt and effective treatment could reduce the parasite reservoir and the possibility of further transmission. Effective surveillance, community engagement and health education, meanwhile, enhanced the ability of authorities to respond, and mobilised popular support for the campaign. The adaptation and flexibility of strategies and support from key partners such as WHO and the Global Fund to Fight AIDS, Tuberculosis and Malaria fast-tracked success.
By 2006, the country recorded less than 1 000 cases of malaria per year, and since October 2012, the indigenous cases were down to zero. For the past three-and-a-half years, no locally transmitted cases have been recorded. To maintain elimination and ensure the parasite is not reintroduced to the country, the anti-malaria campaign is working closely with local authorities and international partners to maintain surveillance and response capacity and to screen high-risk populations entering the country.
Sri Lanka is the second country in the WHO South-East Asia Region to eliminate malaria after Maldives. The announcement of Sri Lanka’s victory over malaria was made at the WHO South-East Asia Region’s annual Regional Committee meeting in the presence of health ministers and senior health officials from all 11 Member States.
The Regional Director said WHO will continue to support the efforts of Sri Lanka’s health authorities as they relate to malaria, as well as the country’s wider public health mission. This outstanding achievement should be a springboard to further public health gains in the country and the South-East Asia Region as a whole. (IANS)
Languishing with fever and frustrated by delays in diagnosing his illness, Brian Gitta came up with a bright idea: a malaria test that would not need blood samples or specialized laboratory technicians.
That inspiration has won the 25-year-old Ugandan computer scientist a prestigious engineering prize for a noninvasive malaria test kit that he hopes will be widely used across Africa.
For developing the reusable test kit known as Matibabu, Gitta this month was awarded the Africa Prize for Engineering Innovation. The award by the Royal Academy of Engineering in Britain comes with $32,940.
Malaria is the biggest killer in Africa, and the sub-Saharan region accounts for about 80 percent of the world’s malaria cases and deaths. Cases rose to 216 million in 2016, up from 211 million cases in 2015, according to the latest World Malaria Report, released late last year. Malaria deaths fell by 1,000, to 445,000.
The mosquito-borne disease is a challenge to prevent, with increasing resistance reported to both drugs and insecticides.
The new malaria test kit works by shining a red beam of light onto a finger to detect changes in the shape, color and concentration of red blood cells, all of which are affected by malaria. The results are sent within a minute to a computer or mobile phone linked to the device.
A Portugal-based firm has been contracted to produce the components for Matibabu, the Swahili word for “treatment.”
“It’s a perfect example of how engineering can unlock development, in this case by improving health care,” Rebecca Enonchong, Africa Prize for Engineering Innovation judge, said in a statement. “Matibabu is simply a game changer.”
Gitta and five colleagues, all trained in computer science or engineering, developed an affordable, bloodless test that does not need a specialist to operate. The new test will be suitable for use in Africa’s rural areas, where most cases of malaria occur, because it will not depend on sending blood samples to a distant laboratory.
Others are also working to fill the need for quicker, easier malaria tests. There are more than 200 rapid diagnostic test products for malaria on the market, according to the WHO.
80 percent accurate now
The fifth-generation prototype of Matibabu, with an accuracy rate of 80 percent, is still a work in process. Gitta and his group aim to refine the device until it achieves an accuracy rate exceeding 90 percent.
Matibabu has yet to be formally subjected to all the necessary clinical trials under Ugandan safety and ethics regulations.
“It excites me as a clinician,” said Medard Bitekyerezo, a Ugandan physician who chairs the National Drug Authority. “I think the National Drug Authority will approve it.”
The government should invest in the project so that its developers don’t struggle financially, he added. The unit cost of the latest prototype is about $100.
Despite the optimism, Gitta has found a hurdle he didn’t anticipate: Some patients are skeptical of unfamiliar technology.
“The doctors will tell you that some people will not leave the hospital until their children have been pricked, and until they have been given anti-malaria drugs and painkillers, even if the kid is not sick,” he said.